BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 35646967)

  • 21. Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.
    Riihilä P; Viiklepp K; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Peltonen J; Peltonen S; Kähäri VM
    Br J Dermatol; 2020 Mar; 182(3):658-670. PubMed ID: 31049937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma.
    Riihilä P; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Grénman R; Peltonen S; Peltonen J; Pihlajaniemi T; Heljasvaara R; Kähäri VM
    Am J Pathol; 2017 May; 187(5):1186-1197. PubMed ID: 28322200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis.
    Cañueto J; Tejera-Vaquerizo A; Redondo P; Botella-Estrada R; Puig S; Sanmartin O
    Actas Dermosifiliogr (Engl Ed); 2020 May; 111(4):281-290. PubMed ID: 32359704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ASSOCIATION OF SKIN PHOTOTYPE AND UV EXPOSURE WITH EXPRESSION OF HER RECEPTORS, Ki67 AND p53 IN PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA].
    Drvar DL; Lipozenčić J; Mokos ZB; Ilić I; Knežević F
    Acta Med Croatica; 2015; 69(5):431-8. PubMed ID: 29087088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.
    Venables ZC; Nijsten T; Wong KF; Autier P; Broggio J; Deas A; Harwood CA; Hollestein LM; Langan SM; Morgan E; Proby CM; Rashbass J; Leigh IM
    Br J Dermatol; 2019 Sep; 181(3):474-482. PubMed ID: 30864158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.
    Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W
    J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
    Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
    J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
    Vidovic D; Simms GA; Pasternak S; Walsh M; Peltekian K; Stein J; Helyer LK; Giacomantonio CA
    Front Immunol; 2021; 12():678028. PubMed ID: 34122442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Disregulation in Cutaneous Squamous Cell Carcinoma of Patients with Recessive Dystrophic Epidermolysis Bullosa: A Single Pilot Study.
    Filoni A; Cicco G; Cazzato G; Bosco A; Lospalluti L; Tucci M; Cimmino A; Foti C; Marzullo A; Bonamonte D
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive cutaneous squamous cell carcinoma of scalp: A case report.
    Dahal A; Neupane D; Lageju N; Jaiswal LS; Chaudhary S; Budhathoki AC; Sah SP; Subedi SS
    Ann Med Surg (Lond); 2022 Oct; 82():104702. PubMed ID: 36268452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas.
    Li X; Zhang C; Yuan Y; Wang Y; Lu S; Zhou Z; Zhen P; Zhou M
    J Dermatol Sci; 2021 Jun; 102(3):184-192. PubMed ID: 34016486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orobol, 3'-hydroxy-genistein, suppresses the development and regrowth of cutaneous SCC.
    Roh E; Kim JE; Zhang T; Shin SH; Kim BG; Li J; Ma X; Lee KW; Dong Z
    Biochem Pharmacol; 2023 Mar; 209():115415. PubMed ID: 36657604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma.
    Piipponen M; Riihilä P; Nissinen L; Kähäri VM
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
    Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y
    J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma.
    Galer CE; Corey CL; Wang Z; Younes MN; Gomez-Rivera F; Jasser SA; Ludwig DL; El-Naggar AK; Weber RS; Myers JN
    Head Neck; 2011 Feb; 33(2):189-98. PubMed ID: 20848439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.
    Farberg AS; Fitzgerald AL; Ibrahim SF; Tolkachjov SN; Soleymani T; Douglas LM; Kurley SJ; Arron ST
    Dermatol Ther (Heidelb); 2022 Feb; 12(2):267-284. PubMed ID: 34994967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.
    Olasz EB; Seline LN; Schock AM; Duncan NE; Lopez A; Lazar J; Flister MJ; Lu Y; Liu P; Sokumbi O; Harwood CA; Proby CM; Neuburg M; Lazarova Z
    PLoS One; 2015; 10(5):e0125412. PubMed ID: 25938461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk among p53 family members in cutaneous carcinoma.
    Missero C; Antonini D
    Exp Dermatol; 2014 Mar; 23(3):143-6. PubMed ID: 24417641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
    Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
    Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1.
    Zhou J; Zhang Y; Han Z; Dong Z; Cao T; Wei A; Guo P; Meng Q
    Cell Cycle; 2019 Feb; 18(3):333-345. PubMed ID: 30646812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.